Clinical Trial Update: Platelet-Rich Plasma vs Corticosteroid Injection as Treatment for Degenerative Pathology of the Temporomandibular Joint [Phase 1]

View source ↗

Summary

A Phase 1 trial comparing platelet-rich plasma to corticosteroid injections for degenerative pathology of the temporomandibular joint has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Temporomandibular Joint

Drugs mentioned

• Corticosteroid injection (corticosteroid)
• Platelet-rich plasma (platelet-rich plasma)

Snippet

Sponsor: Kaiser Permanente | Conditions: Degenerative Joint Disease | Phase 1 | Status: WITHDRAWN